CARTA CIENTÍFICA
Eficacia terapéutica de exenatida en una paciente con síndrome de Prader-Willi
Therapeutic effectiveness of exenatide in a patient with Prader-Willi syndrome
José Pérez-Rodríguez
, Isabel Serrano-Olmedo, Cristóbal Morales-Portillo, Clara García-García, Virginia Hernando-Jiménez, Tomás Martín-Hernández
Autor para correspondencia
Servicio de Endocrinología y Nutrición, Hospital Universitario Virgen Macarena, Sevilla, España
Leído
5006
Vecesse ha leído el artículo
1193
Total PDF
3813
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 9 | 7 | 16 |
| 2025 11 | 38 | 41 | 79 |
| 2025 10 | 23 | 16 | 39 |
| 2025 9 | 33 | 13 | 46 |
| 2025 8 | 45 | 9 | 54 |
| 2025 7 | 39 | 8 | 47 |
| 2025 6 | 55 | 6 | 61 |
| 2025 5 | 33 | 3 | 36 |
| 2025 4 | 28 | 3 | 31 |
| 2025 3 | 41 | 7 | 48 |
| 2025 2 | 34 | 1 | 35 |
| 2025 1 | 27 | 9 | 36 |
| 2024 12 | 27 | 7 | 34 |
| 2024 11 | 36 | 9 | 45 |
| 2024 10 | 36 | 3 | 39 |
| 2024 9 | 22 | 4 | 26 |
| 2024 8 | 21 | 7 | 28 |
| 2024 7 | 16 | 7 | 23 |
| 2024 6 | 42 | 20 | 62 |
| 2024 5 | 47 | 6 | 53 |
| 2024 4 | 37 | 6 | 43 |
| 2024 3 | 43 | 14 | 57 |
| 2024 2 | 30 | 19 | 49 |
| 2024 1 | 52 | 9 | 61 |
| 2023 12 | 58 | 13 | 71 |
| 2023 11 | 34 | 18 | 52 |
| 2023 10 | 61 | 9 | 70 |
| 2023 9 | 46 | 7 | 53 |
| 2023 8 | 32 | 7 | 39 |
| 2023 7 | 33 | 8 | 41 |
| 2023 6 | 34 | 8 | 42 |
| 2023 5 | 41 | 2 | 43 |
| 2023 4 | 31 | 18 | 49 |
| 2023 3 | 26 | 4 | 30 |
| 2023 2 | 28 | 3 | 31 |
| 2022 1 | 19 | 13 | 32 |
| 2022 12 | 42 | 22 | 64 |
| 2022 11 | 41 | 16 | 57 |
| 2022 10 | 63 | 19 | 82 |
| 2022 9 | 34 | 51 | 85 |
| 2022 8 | 37 | 24 | 61 |
| 2022 7 | 22 | 17 | 39 |
| 2022 6 | 32 | 13 | 45 |
| 2022 5 | 28 | 12 | 40 |
| 2022 4 | 21 | 12 | 33 |
| 2022 3 | 40 | 11 | 51 |
| 2022 2 | 45 | 3 | 48 |
| 2021 1 | 39 | 12 | 51 |
| 2021 12 | 47 | 9 | 56 |
| 2021 11 | 40 | 8 | 48 |
| 2021 10 | 73 | 19 | 92 |
| 2021 9 | 38 | 8 | 46 |
| 2021 8 | 31 | 5 | 36 |
| 2021 7 | 19 | 14 | 33 |
| 2021 6 | 22 | 7 | 29 |
| 2021 5 | 25 | 5 | 30 |
| 2021 4 | 104 | 13 | 117 |
| 2021 3 | 54 | 10 | 64 |
| 2021 2 | 41 | 8 | 49 |
| 2020 1 | 54 | 12 | 66 |
| 2020 12 | 48 | 13 | 61 |
| 2020 11 | 27 | 8 | 35 |
| 2020 10 | 25 | 5 | 30 |
| 2020 9 | 23 | 11 | 34 |
| 2020 8 | 40 | 8 | 48 |
| 2020 7 | 23 | 7 | 30 |
| 2020 6 | 19 | 20 | 39 |
| 2020 5 | 25 | 13 | 38 |
| 2020 4 | 34 | 7 | 41 |
| 2020 3 | 32 | 8 | 40 |
| 2020 2 | 34 | 5 | 39 |
| 2020 1 | 24 | 12 | 36 |
| 2019 12 | 37 | 7 | 44 |
| 2019 11 | 25 | 11 | 36 |
| 2019 10 | 35 | 6 | 41 |
| 2019 9 | 25 | 9 | 34 |
| 2019 8 | 18 | 5 | 23 |
| 2019 7 | 26 | 10 | 36 |
| 2019 6 | 59 | 24 | 83 |
| 2019 5 | 139 | 8 | 147 |
| 2019 4 | 65 | 17 | 82 |
| 2019 3 | 17 | 9 | 26 |
| 2019 2 | 23 | 23 | 46 |
| 2019 1 | 9 | 9 | 18 |
| 2018 12 | 19 | 8 | 27 |
| 2018 11 | 31 | 18 | 49 |
| 2018 10 | 37 | 12 | 49 |
| 2018 9 | 17 | 9 | 26 |
| 2018 8 | 19 | 5 | 24 |
| 2018 7 | 10 | 8 | 18 |
| 2018 6 | 10 | 4 | 14 |
| 2018 5 | 12 | 5 | 17 |
| 2018 4 | 11 | 2 | 13 |
| 2018 3 | 14 | 1 | 15 |
| 2018 2 | 5 | 1 | 6 |
| 2018 1 | 11 | 5 | 16 |
| 2017 12 | 5 | 2 | 7 |
| 2017 11 | 7 | 0 | 7 |
| 2017 10 | 10 | 2 | 12 |
| 2017 9 | 11 | 8 | 19 |
| 2017 8 | 6 | 1 | 7 |
| 2017 7 | 9 | 1 | 10 |
| 2017 6 | 18 | 10 | 28 |
| 2017 5 | 27 | 4 | 31 |
| 2017 4 | 17 | 3 | 20 |
| 2017 3 | 30 | 30 | 60 |
| 2017 2 | 24 | 7 | 31 |
| 2016 1 | 22 | 4 | 26 |
| 2016 12 | 25 | 7 | 32 |
| 2016 11 | 27 | 9 | 36 |
| 2016 10 | 40 | 18 | 58 |
| 2016 9 | 42 | 6 | 48 |
| 2016 8 | 30 | 1 | 31 |
| 2016 7 | 25 | 1 | 26 |
| 2016 6 | 24 | 20 | 44 |
| 2016 5 | 22 | 13 | 35 |
| 2016 4 | 20 | 5 | 25 |
| 2016 3 | 35 | 11 | 46 |
| 2016 2 | 22 | 10 | 32 |
| 2015 1 | 25 | 8 | 33 |
| 2015 5 | 2 | 1 | 3 |
| 2015 4 | 4 | 2 | 6 |
| 2015 3 | 6 | 2 | 8 |
| 2015 2 | 1 | 0 | 1 |
Mostrar todo
